Todd Pietri

Todd Pietri co-founded Milestone Venture Partners with Ed Goodman in October 1999. He brings operating and investment experience to its man

Todd Pietri
new-york-new-york

Todd Pietri co-founded Milestone Venture Partners with Ed Goodman in October 1999. He brings operating and investment experience to its management. Since launching MVP II in 2001, Todd Pietri has developed expertise and relationships in the financial services IT, pharmaceutical IT, healthcare media, and outsourced business service sectors. Todd Pietri is responsible for nine Milestone investments: BizBash Media, Derivatives Portfolio Management (successfully sold to Mellon Financial in February 2005), GenomeQuest, Oddcast, SmartAnalyst, MedPage Today, MDX Medical ("Vitals"), Peridrome and TargetSpot. His earlier financial experience includes co-heading the Technology and Communications Investment Banking Group at Legacy Securities, where he performed a broad range of capital raising, M&A and other financial advisory services. Todd Pietri was also a member of Legacy’s direct investment team, which provided mezzanine and growth equity through its affiliate, Legacy Capital Partners. Todd Pietri gained valuable control and turn-around investment experience as an Associate at Callier Interests, a turn-around leveraged buy-out firm focused on middle market industrial distributors and manufacturers. Todd Pietri’s operating experience includes direct sales, sales management, channel management, business development and business process consulting. He also possesses technical expertise in computer telephony systems and enterprise resource planning software. From 1992 to 1997, he ran IT consulting and direct sales for CompuSystems, an Atlanta-based software and services firm focused on industrial distributors and manufacturers. He and his team provided solutions for inventory control, order processing, and financial reporting. Prior to his tenure at CompuSystems, Todd Pietri worked in the voice processing industry for Innovative Technology, Call Response Automation and his own consulting firm.

Investment Focus
Stages
seed
Markets
Biotech / Pharma
Links
No public links
Contacts
Unlock contacts with credits
Share this page